Financial Year |
March 31 2023 |
Monetary Funds |
37,977,274,148.77 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
12,012,981,243.30 |
Advances to Suppliers |
1,735,313,063.08 |
Other Receivables |
1,193,212,404.36 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
18,317,804,765.96 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,774,769,454.82 |
Total Current Assets |
77,735,146,715.56 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
914,786,155.19 |
Long-term Equity Investment |
6,383,747,129.64 |
Investment Properties |
-- |
Fixed Assetes |
83,847,975,964.66 |
Under-construction Projects |
37,626,832,492.24 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
9,855,515,755.89 |
R&D expenses |
-- |
Goodwill |
1,302,040,145.54 |
Long-Term Deferred and Prepaid Expenses |
27,880,538.43 |
Deferred Income Tax Assets |
2,968,808,041.63 |
Other Non-Current Assets |
9,138,729,949.30 |
Sub-Total of Non-Current Assets |
160,058,639,750.68 |
Total Assets |
237,793,786,466.24 |
Short-Term Loans |
70,482,269,553.70 |
Trading Financial liabilities |
-- |
Notes Payable |
15,364,990,915.77 |
Accounts Payable |
12,897,358,898.77 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
927,488,415.60 |
Taxes Payable |
1,852,312,177.54 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,286,350,785.39 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,834,700,254.15 |
Other Current Liabilities |
9,474,002,847.59 |
Sub-Total of Current Liabilities |
120,633,788,459.64 |
Long-term Loans |
21,714,933,031.42 |
Bonds Payable |
200,000,000.00 |
Long-Term Accounts Payable |
161,326,346.25 |
Special Payable |
-- |
Estimatied Liabilities |
244,478,084.50 |
Deferred Income Tax Liabilities |
398,607,786.61 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
31,385,218,819.46 |
Total Liabilities |
152,019,007,279.10 |
Paid-In Capital(Or Share Stock) |
3,139,746,626.00 |
Capital Surplus |
2,160,686,415.61 |
Surplus Reserve |
2,823,172,641.71 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
73,285,224,587.13 |
Minority Stockholder's Interest |
4,837,785,825.56 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
80,936,993,361.58 |
Owner's Equity(Stockholder's Equity) |
85,774,779,187.14 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
237,793,786,466.24 |